News: Study Predicts Growth for Needle-Free Injection Market
The market for needle-free injection (NFI) products should grow at a healthy pace over the next few years, according to a new study by industry consulting firm Greystone Associates (Amherst, NH). The study, titled, “Needle-free Injection: Players, Products, and Prospects,” was published in early December and contains comprehensive evaluation and analysis of the technology and products behind this noninvasive segment of the parenteral drug-delivery sector.
As the study points out, NFI is a relatively recent trend that has been building steam with the convergence of synthetic materials and computerized design software. Reliable and cost-effective devices continue to hit the market. In addition, new NFI product designs currently under development are expected to soon create new opportunities for the segment. For example, reusable injectors designed to accept prefilled syringes or drug cartridges will improve ease-of-use and increase NFI share of the market. Disposable prefilled NFI models will also likely penetrate selected practitioner segments such as wellness vaccines. Also, partnerships between NFI suppliers and pharmaceutical companies should lead to market acceptance of NFI for a host of new therapies such as therapeutic vaccines, DNA-based drugs, and protein-derived biologics.
The study also predicts that key growth for NFI will be in self-injection (insulin, hGH) and, over the course of the next 10 years, in vaccines, DNA-based drugs, and protein-based medicines. Strategic alliances with pharmaceutical companies will be the key enabler for NFI participants. The study also states that the majority of NFI suppliers are now engaged in one or more partnerships with pharmaceutical companies.
Other conclusions from the study:
• Needle-free systems are gaining market share at the expense of traditional syringes.
• New materials and advanced design concepts are increasing the ability of needle-free injectors to satisfy a growing number of parenteral drug-delivery protocols.
• Concern for the well-being of healthcare providers and issues with safety syringe designs are creating growth opportunities for needle-free systems.
• The trend toward increased home care and drug therapy self-administration will help drive incremental needle-free unit sales.